drugset
drugset / Trial / NCT02172209

Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers

NCT02172209 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Trial to assess the effect of food on the pharmacokinetics and the extent of absorption of a single dose BI 10773 tablet in healthy subjects

Timeline

Start
2008-01
Primary completion
2008-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule 50 mg Oral

Indications

No indication recorded.